Previous Article | Next Article ![]()
Journal of Virology, November 2006, p. 11105-11114, Vol. 80, No. 22
0022-538X/06/$08.00+0 doi:10.1128/JVI.00846-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
McArdle Laboratory for Cancer Research, University of WisconsinMadison, Madison, Wisconsin 53706
Received 24 April 2006/ Accepted 28 August 2006
The Kaposi's sarcoma-associated herpesvirus (KSHV) envelope glycoprotein gpK8.1 contributes to cellular attachment through binding cell surface heparan sulfate proteoglycans. By using a soluble recombinant form of gpK8.1, we discovered that a consequence of gpK8.1 interaction with human fibroblasts is the induction of an antiviral response, as characterized by the activation of interferon regulatory factor 3 (IRF-3), production of interferon beta (IFN-ß), and expression of interferon-stimulated antiviral genes. In contrast, neither IFN-ß expression nor a functional antiviral response is observed in cells treated with KSHV virions. The interferon response induced by soluble gpK8.1 can be inhibited by simultaneous treatment with UV-inactivated virions, while the induction of an indicator inflammatory cytokine, interleukin-6, was readily evident in the response to both gpK8.1 and KSHV. In addition, KSHV virions abrogate gpK8.1-mediated activation of IRF-3, an early transcriptional regulator for cellular antiviral responses. Although innate immune responses are initiated during contact between gpK8.1 and cellular receptor(s), these results suggest that the virion contains one or more structural elements that selectively repress an effective antiviral response while allowing cellular responses favorable to the KSHV life cycle.
Published ahead of print on 6 September 2006.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»